Literature DB >> 24132558

Dabigatran and rivaroxaban prescription for atrial fibrillation in Catalonia, Spain: the need to manage the introduction of new drugs.

Amelia Troncoso1, Eduard Diogène.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24132558     DOI： 10.1007/s00228-013-1593-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  Bleeding risk with dabigatran in the frail elderly.

Authors:  Paul Harper; Laura Young; Eileen Merriman
Journal:  N Engl J Med       Date:  2012-03-01       Impact factor: 91.245

2.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Authors:  Manesh R Patel; Kenneth W Mahaffey; Jyotsna Garg; Guohua Pan; Daniel E Singer; Werner Hacke; Günter Breithardt; Jonathan L Halperin; Graeme J Hankey; Jonathan P Piccini; Richard C Becker; Christopher C Nessel; John F Paolini; Scott D Berkowitz; Keith A A Fox; Robert M Califf
Journal:  N Engl J Med       Date:  2011-08-10       Impact factor: 91.245

3.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245
  3 in total
  9 in total

1.  Anticoagulation in atrial fibrillation: NOAC prescribing in primary health care.

Authors:  Carla Bastida; Núria Corominas; José Miguel Sotoca; Marina Rovira
Journal:  Int J Clin Pharm       Date:  2017-02-10

Review 2.  Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.

Authors:  Brian Godman; Rickard E Malmström; Eduardo Diogene; Sisira Jayathissa; Stuart McTaggart; Thomas Cars; Samantha Alvarez-Madrazo; Christoph Baumgärtel; Anna Brzezinska; Anna Bucsics; Stephen Campbell; Irene Eriksson; Alexander Finlayson; Jurij Fürst; Kristina Garuoliene; Iñaki Gutiérrez-Ibarluzea; Krystyna Hviding; Harald Herholz; Roberta Joppi; Marija Kalaba; Ott Laius; Kamila Malinowska; Hanne B Pedersen; Vanda Markovic-Pekovic; Jutta Piessnegger; Gisbert Selke; Catherine Sermet; Susan Spillane; Dominik Tomek; Luka Vončina; Vera Vlahović-Palčevski; Janet Wale; Magdalena Wladysiuk; Menno van Woerkom; Corinne Zara; Lars L Gustafsson
Journal:  Front Pharmacol       Date:  2014-06-10       Impact factor: 5.810

Review 3.  Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.

Authors:  Patricia Vella Bonanno; Michael Ermisch; Brian Godman; Antony P Martin; Jesper Van Den Bergh; Liudmila Bezmelnitsyna; Anna Bucsics; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Irene Eriksson; Jurij Fürst; Mohamed Gad; Ieva Greičiūtė-Kuprijanov; Martin van der Graaff; Jolanta Gulbinovic; Jan Jones; Roberta Joppi; Marija Kalaba; Ott Laius; Irene Langner; Ileana Mardare; Vanda Markovic-Pekovic; Einar Magnusson; Oyvind Melien; Dmitry O Meshkov; Guenka I Petrova; Gisbert Selke; Catherine Sermet; Steven Simoens; Ad Schuurman; Ricardo Ramos; Jorge Rodrigues; Corinne Zara; Eva Zebedin-Brandl; Alan Haycox
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

4.  [Effectiveness, safety and costs of stroke prevention in non-valvular auricular fibrillation. Study of cohorts matched by Propensity score].

Authors:  Maria Giner-Soriano; Marc Casajuana; Albert Roso-Llorach; Cristina Vedia; Rosa Morros
Journal:  Aten Primaria       Date:  2019-09-21       Impact factor: 1.137

5.  Oral Anticoagulant Adequacy in Non-Valvular Atrial Fibrillation in Primary Care: A Cross-Sectional Study Using Real-World Data (Fantas-TIC Study).

Authors:  M Rosa Dalmau Llorca; Carina Aguilar Martín; Noèlia Carrasco-Querol; Zojaina Hernández Rojas; Emma Forcadell Drago; Dolores Rodríguez Cumplido; Josep M Pepió Vilaubí; Elisabet Castro Blanco; Alessandra Q Gonçalves; José Fernández-Sáez
Journal:  Int J Environ Res Public Health       Date:  2021-02-24       Impact factor: 3.390

6.  Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis.

Authors:  Abdulrhman Al Rowily; Zahraa Jalal; Malcolm J Price; Mohammed H Abutaleb; Hind Almodiaemgh; Maha Al Ammari; Vibhu Paudyal
Journal:  Eur J Clin Pharmacol       Date:  2021-12-22       Impact factor: 2.953

7.  Preventive strategies against bleeding due to nonvitamin K antagonist oral anticoagulants.

Authors:  Sarah Lessire; Lessire Sarah; Anne-Sophie Dincq; Dincq Anne-Sophie; Jonathan Douxfils; Douxfils Jonathan; Bérangère Devalet; Devalet Bérangère; Jean-Baptiste Nicolas; Nicolas Jean-Baptiste; Anne Spinewine; Spinewine Anne; Anne-Sophie Larock; Larock Anne-Sophie; Jean-Michel Dogné; Dogné Jean-Michel; Maximilien Gourdin; Gourdin Maximilien; François Mullier; Mullier François
Journal:  Biomed Res Int       Date:  2014-06-16       Impact factor: 3.411

8.  Clinical utility of dabigatran in United Arab Emirates. A pharmacovigilance study.

Authors:  Abdulla Shehab; Asim A Elnour; Adel Sadik; Mahmoud Abu Mandil; Ali AlShamsi; Aesha Al Suwaidi; AkshayaSrikanth Bhagavathula; Pinar Erkekoglu; Farah Hamad; Saif K Al Nuaimi
Journal:  Saudi Med J       Date:  2015-11       Impact factor: 1.484

9.  Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions.

Authors:  Mohamed Gad; Ahmed Salem; Wija Oortwijn; Ruaraidh Hill; Brian Godman
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.